CD8A and neoplasm: Intriguingly, they found that the number of effector/memory CD8+ T lymphocytes (CCR7−CD45RA−)76 decreased, while that of exhausted tumor‐reactive CD8+ T lymphocytes (TIGIT+ PD‐1+)77 increased in HPD patients with NSCLC.